Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-07-21 @ 5:46 AM
Study NCT ID:
NCT00372567
Status:
TERMINATED
Last Update Posted:
2011-03-17
First Post:
2006-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A6181112
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc